Dear Health IT Colleagues,
This is an invitation to contribute your voice into the development of World Health Organization Guidelines on the use of digital tools for health systems strengthening. Please note that we ask that you submit your responses to this follow-up survey by Tuesday, December 20th. This survey will take approximately 10 minutes, and your inputs will provide valuable insights for prioritization the specific digital interventions that should be addressed in the upcoming guidelines. This is the second (refined) phase of prioritization of topics following expert review in September, and will serve as the basis for the development of the systematic reviews that will lead to WHO Guidance being released in 2017.
Link to the survey: http://bit.ly/Digital_Guideline
The World Health Organization’s Department of Reproductive Health (RHR) and Research formally initiated the process of developing Guidelines featuring evidence-based recommendations on the use of digital strategies to improve health systems including those serving reproductive, maternal, newborn, child, and adolescent health (RMNCAH), and accountability mechanisms. This guideline development comes as an explicit response to requests from UN member states Ministries of Health for WHO to develop formal guidance on determining which digital health strategies are evidence-based and offer comparative value. Recommendations emerging from this Guideline are intended to support National objectives including those reflected in the UN Sustainable Development Goals, and the Global Strategy for Women’s, Children’s and Adolescents’ Health, and serve as a resource to the Health Data Collaborative mechanism.
As part of the Guideline development process, key research questions have been drafted as areas for further examination on the evidence supporting the use of digital strategies for RMNCAH. Although these questions have been refined through a consultative process with an WHO advisory group and previous survey feedback, would would like to provide a final opportunity to rank and prioritize questions that should be addressed in the upcoming Guideline.
Thank you in advance for your valuable contributions to this survey and to the ongoing WHO Guideline development process.
Garrett Mehl, PhD, MHS
Department of Reproductive Health and Research, includes
HRP - the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research in Human Reproduction
World Health Organization
20 Avenue Appia